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A new synthesis in search of synthesizing agents
Comment on “A new synthesis” 
In an editorial in this journal Pierre-Gerlier Forest (1) foretells a revolution in health policy and, consequently, in healthcare, a revolution that is four-pronged but revolves around the 
intellectual emergence of a central concept of “integration” 
(more on this later). Not only “integration of care” which, 
as Forest rightfully writes “makes no sense if not informed” 
by something else (in his words, “patients capabilities”), but 
integration of all that contributes to population health. The 
revolution pushes providers to not work in isolation or at arm’s 
length from “society”—this is the biosocial stress perspective 
—or policy-makers—thanks to a combination of new tools of 
government and a better understanding of medical decision-
making through behavioral economics—or, as importantly, 
in isolation from each other—thanks to the realization that 
problems in the healthcare system are not those of individual 
providers, but systemic in essence. This is an idea-driven 
revolution in which a series of intellectual innovations, helped 
by the advent of better technology (big data) gives birth to a 
new paradigm, which itself transforms the way things happen 
on the ground. Last, PG Forest is not only the chronicler of the 
revolution, but also one of its actors and proponents, certainly 
more of a Camille Desmoulins than an Edmund Burke. 
The story as told is compelling and not easy to dismiss. In this 
commentary, I will play the devil’s advocate, trying to curb 
enthusiasms for the coming revolution. To do this, I will not 
use the standard argument (rather posture) of the conservative 
curmudgeon stating that what looks like new and innovative is 
really old tricks under a new name. I will not, because I sincerely 
believe that all four advances contributing the revolution 
are, indeed, new and revolutionary. In the realm of ideas and 
concepts, these are path-breaking and have an obvious ability 
to change our perceptions of the way health systems work 
(or do not work as they should). Serious exploration and 
measurement of the effects of social hierarchies on health (and 
health inequalities) is a new field of research, now free from 
ideological imprecations from the left (hierarchies must kill 
because they are bad) or stubborn denials from the right (“there 
is no such thing as society”), health economists are more likely 
to investigate behavior than other economists and to apply 
behavioral tools to the understanding of medical or health-
related decisions, and health services research is accumulating 
findings that will change the way we understand evidence-
based medicine and policy. 
My line of argument is that paradigm shifts do translate on 
the ground if and only if actors and structures are willing to 
adopt them or, at least, if one group of determined agents of 
change are willing to take the risk and bear the cost of waging 
the revolution. A good example to the contrary is Ignaz 
Semmelweis’s discovery of the simple prophylaxis of puerperal 
fever through hand washing in 1847. Not only his discovery was 
not taken up until long after his death, but it can be claimed he 
lost his reason and his life for having discovered an inconvenient 
truth. 
To follow the metaphor used by PG Forest in his editorial, 
the first revolution that took place in the 1970s around the 
notion that healthcare resources should satisfy some objective 
needs rather than all that the doctor ordered and the patient 
wanted was certainly helped by Donabedian’s concepts but 
would certainly not have been feasible if payers had not won 
the initial battle to cover healthcare costs. Private insurers (Blue 
Cross) faced the same uphill battles as public ones when trying 
to create something called “the financial risk associated with 
healthcare” because doctors (and pharmaceutical companies 
to a lesser extent) knew very well that such coverage would 
ineluctably end up as inquisitive intrusion in the “clinical 
encounter”. The counter-revolution of the day urged that the 
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best health insurance was technological innovation. However, 
once insurers had won the day they desperately needed a 
conceptual framework to help them manage the risk and bend 
the infamous cost curve. Doctors were right to be scared and 
they had seen Donabedian coming decades ahead of time. 
Similarly, evidence-based medicine (the second revolution 
in healthcare according to PG Forest) has become orthodoxy 
not only by virtue of being articulated but, again, because it 
served the purposes of “statistical buyers of care” (either single-
payers in public schemes or private insurers in competition), 
and accompanied the transformation of social medicine into 
managed competition in the US healthcare system. Medical 
groups practicing a cost-efficient medicine for the working 
and middle classes, often eager to help the poor, became health 
maintenance organizations competing for coverage of big 
corporations. This is the result of Richard Nixon shrewdly using 
well-meaning and efficient doctors and nurses as a Trojan horse 
into the citadel of universal health insurance. To counter social 
insurance, the movement toward health maintenance, and as a 
result, evidence-based medicine was launched. 
What these two revolutions and the one in coming have in 
common is a societal evolution: healthcare is less a personal 
service resulting from the clinical encounter (and idiosyncratic 
interactions between providers and patients) and more of 
a product that can be evaluated (at least statistically). The 
main outcome of such an evolution is clinical governance: 
providers are held accountable, possibly even liable, not only 
for undesirable events, but also more broadly for improper use 
of resources that could have been put to better use elsewhere 
(opportunity costs liability). This standardization and, some 
would say nostalgically, commodification of healthcare has 
been a trend in almost all healthcare systems, whether public 
or private. Simultaneously and logically connected, providers of 
this more and more standardized product are paid on the basis 
of outcomes rather than merely for what they do. A growing 
proportion of doctors in most countries now receive a growing 
proportion of their income on a capitated basis rather than 
fee-for-services, and primary care teams in which individual 
remunerations are based on contribution to activity rather 
than on unionized wages or professional fees flourish in many 
part of the world. It can even be said that hospitals have moved 
from a general obligation to provide what hospitals are meant 
to provide (under global budget) to being paid for producing 
something that can be tracked and measured (treatment of a 
given case based on prices per diagnosis-related groups). 
The next revolution will change things on the ground if 
some agents of change want clinical governance to extend to 
population health. The intellectual tools are ready to be used 
but the question is whether economic and social conditions are 
ripe to see their use on a scale that would trigger a revolution. 
The question is: will doctors and other professionals fight 
back or will they have to accept more clinical governance at 
the population level this time? My guess is that we will see 
some more of the same evolution toward standardization and 
accountability taking place, but also the same lines of resistance 
opposed by doctors and nurses (and drug companies). My 
description of the evolution above made it look like some kind of 
inexorable Behemoth mercilessly crushed physicians’ autonomy 
and the mystery of clinical encounter. The truth is, of course, 
that professionals managed to save a lot from the onslaught of 
standardized medicine: in healthcare it is still labor hiring capital 
and the autonomy of the profession running the show. Doctors 
may be more accountable and liable than fifty years ago, but 
they keep a massive advantage over agents of standardization, 
a not-so-secret weapon: their patients’ trust. For all the noise 
about “internet medicine”, it is still the case that patients want 
their family doctor (not a doctor in a walk-in clinic) to make 
clinical decisions, even though these decisions must now be 
in accordance with statistical evidence known by the patient. 
What the patient knows they do not know, because it is not 
in the publications, is the fine-grained, almost idiosyncratic 
information on how this particular illness will evolve or is 
supposed to evolve in their particular case. As a result, patients 
(and tax-payers as patients in the making) are always going 
to go with their doctor against their payer. The managed care 
backlash of the late 1990s in the US clearly showed that patients 
with chronic illnesses or in need of regular care rejected closed 
panel medicine, mostly because they did not want to lose the 
right to see “their” doctor: if an insurer were to exclude my 
family doctor from their panel I would quit my insurer and 
follow my doctor. The lesson, therefore, seems to be that we 
embrace standardization in medicine but we remain attached 
to personal relationships, and we are ready to pay for it. We are 
going to move toward more clinical governance, certainly in the 
direction described by PG Forest, but professional autonomy of 
doctors and nurses will set limits to it.
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